Why Palantir Stock Is Skyrocketing Today

Palantir shares jumped 18.2% at 3:20 p.m. ET after Trump announced a 90-day pause on reciprocal tariffs for all countries except China, where the tariff rate is set to rise from 104% to 125%. The company reiterated guidance for the quarter ended in March of $858M–$862M sales (midpoint +35.6% YoY) and full-year sales of $3.741B–$3.757B (midpoint ~+31%), alongside projected non-GAAP free cash flow of $1.5B–$1.7B (+28% YoY at the midpoint). Despite the tariff-driven macro uncertainty, Palantir is still showing strong momentum, with the stock up 21.5% year-to-date in 2025.

Analysis

This move is mostly a multiple effect, not a revenue effect. A tariff pause reduces near-term recession odds and mechanically bids up the longest-duration software names; PLTR is a clean recipient because its valuation is still driven more by sentiment around AI/platform scarcity than by current cash earnings. The important distinction is that PLTR has limited direct tariff exposure, so the stock is reacting to improved risk appetite rather than a change in its operating model.

The second-order winner is the broader high-growth software basket, while the likely loser is anything whose earnings are more tied to global hardware/industrial supply chains or capital spending sensitivity. If tariff policy remains noisy, PLTR can keep trading as a macro hedge against domestic government/software spend, but that relationship is fragile: a renewed drawdown in the Nasdaq or a worsening trade confrontation with China would quickly pull the stock back toward factor beta. NDAQ also benefits indirectly if higher risk appetite reopens issuance and trading activity, but that effect is more diffuse.

The key watch item is the next guidance print: if management does not trim forward revenue or margin assumptions, today’s move can persist for 1-3 months as investors re-rate the stock on de-risked macro. If, however, enterprise customers delay procurement or government clients slow award timing, the stock can give back the entire tariff-driven gain quickly. The contrarian view is that the market is over-assigning macro sensitivity to PLTR; that makes the rally vulnerable to mean reversion unless there is fresh evidence of acceleration in bookings, not just better sentiment.

Key Decisions for Investors

• Fade the move tactically: buy 4-8 week put spreads on PLTR or short a portion of PLTR against the Nasdaq/AI basket into strength; thesis only works if the stock is trading on macro beta rather than new fundamental data.
• If you want to stay long growth, prefer NVDA or a broader software proxy over PLTR for the next 1-3 months; they have more direct exposure to a risk-on re-rating and less single-name event risk from guidance.
• Use PLTR as a catalyst watch, not a conviction long, until the next earnings call confirms that pipeline conversion and billings are unchanged; if management reiterates full-year growth without a cut, cover any short into that print.
• Pair idea: long NDAQ / short PLTR for a 1-2 month mean-reversion trade if volatility stays elevated; NDAQ benefits from market turnover and issuance, while PLTR is already priced for perfection.
• Falsifier: if PLTR can hold the post-gap gain for several sessions and then re-accelerate on no new macro headlines, the market is telling us this is becoming a standalone momentum name again, not just a tariff-beta trade.